[1]
A. A. Kadhim, M. Y. Jamal, و A. K. Karim, "Natalizumab Immunogenicity in Multiple Sclerosis: Evaluating Antibody Development and Clinical Outcomes in an Iraqi Cohort", Al-Rafidain J Med Sci, م 9, عدد 2, ص 83–89, أكتوبر 2025.